Ufovax is a spin-off vaccine company that employs patented single-component self-assembling protein nanoparticle platform technology. It develops and commercializes B-cell focused, rapid antibody-eliciting, preventive vaccines for challenging diseases . The company delivers vaccine candidates to address human immunodeficiency viruses, respiratory syncytial virus, Ebola/Marburg, Lassa, coronaviruses, and non-viral diseases such as malaria and tuberculosis.
|HQ||Wilmington, DE, US||Map|
When was Ufovax founded?
Ufovax was founded in 2018.
Who are Ufovax key executives?
Ufovax's key executives are Ji Li and Jiang Zhu.
Who are Ufovax competitors?
Competitors of Ufovax include Technovax, Affinivax and Medigen.
Where is Ufovax headquarters?
Ufovax headquarters is located at 3801 Kennett Pike Ste. A101, #4482, Wilmington.
Where are Ufovax offices?
Ufovax has an office in Wilmington.
How many offices does Ufovax have?
Ufovax has 1 office.
Receive alerts for 300+ data fields across thousands of companies